ClinicalTrials.Veeva

Menu
C

California Dermatology & Clinical Research Institute | Encinitas, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Ritlecitinib
PF-04965842
Glycopyrronium
LY3009104
PF-06700841
Baricitinib
JNJ-77242113
CTP-543
Ustekinumab
AIV001

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

15 of 64 total trials

A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo (Tranquillo LTE)

This study is to evaluate how safe and effective ritlecitinib is in participants with non-segmental vitiligo (NSV).Ritlecitinib is studied in patient...

Active, not recruiting
Vitiligo
Drug: Ritlecitinib
Drug: Ritlecitinib 100 mg

The purpose of this clinical trial is to learn about long-term safety and long-term effects of the study medicine (called ritlecitinib) for the poten...

Enrolling
Severe Alopecia Areata
Drug: Ritlecitinib lower dose
Drug: Ritlecitinib higher dose

The purpose of the study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the treatment of alopecia areata. A...

Enrolling
Alopecia Areata
Drug: Placebo - 50 mg
Drug: Ritlecitinib 50 mg

The main purpose of this study is to determine the efficacy and safety of baricitinib for the treatment of severe or very severe alopecia areata (hai...

Enrolling
Hair Diseases
Alopecia
Drug: Placebo
Drug: Baricitinib

The purpose of the study is to evaluate how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo an...

Active, not recruiting
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113 Matching Placebo

The purpose of the study is to see how effective JNJ-77242113 is in participants with plaque psoriasis affecting special areas (scalp, genital, and/o...

Active, not recruiting
Plaque Psoriasis
Drug: Placebo
Drug: JNJ-77242113

The main purpose of this study is to assess how well JNJ-77242113 works when compared to placebo and ustekinumab in participants with moderate to sev...

Active, not recruiting
Plaque Psoriasis
Drug: Ustekinumab
Drug: Matching Placebo to Ustekinumab

Phase 3 study to evaluate the efficacy and safety of subcutaneous tildrakizumab in subjects with moderate to severe genital psoriasis.

Active, not recruiting
Moderate to Severe Genital Psoriasis
Drug: Tildrakizumab 100 mg
Drug: Placebo

The purpose of this study is to learn about the safety and effects of the study medicine (called ritlecitinib) for the possible treatment of severe a...

Enrolling
Severe Alopecia Areata
Drug: Ritlecitinib higher dose
Drug: Placebo

The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic d...

Enrolling
Atopic Dermatitis
Drug: Lebrikizumab

This is a Phase 3 multicenter, double-blind study to evaluate the safety and efficacy of vehicle-controlled topical MOB015B in the treatment of Dista...

Active, not recruiting
Onychomycosis
Drug: MOB015B
Drug: Vehicle (Placebo Comparator)

Multi-center, dose-regimen, double-blind study evaluating the safety and efficacy of 4 doses of SLI-F06 compared with vehicle for improvement in scar...

Enrolling
Wound Healing
Scar
Drug: SLI-F06

The overall objectives of the study are to evaluate long-term safety of CTP-543 and to assess long-term effects of CTP-543 on treating hair loss in a...

Active, not recruiting
Alopecia Areata
Drug: CTP-543

The main purpose of this study is to demonstrate that when participants with moderate to severe plaque psoriasis and obesity or overweight in the pre...

Active, not recruiting
Psoriasis
Obesity
Drug: Tirzepatide
Drug: Ixekizumab

A study to evaluate the long-term safety of Deucravacitinib versus Ustekinumab in participants with psoriasis

Enrolling
Plaque Psoriasis
Drug: Ustekinumab
Drug: Deucravacitinib

Trial sponsors

Pfizer logo
Lilly logo
Janssen (J&J Innovative Medicine) logo
J
A
Concert Pharmaceuticals logo
Nektar Therapeutics logo
P
A
A

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems